CoChat

Role of Glucose-Lowering Medications in Erectile Dysfunction

Open access

The DOI matches its Crossref record; 183 of the 184 references it cites were found in a registry or an index.

Abstract

Erectile dysfunction (ED) is a long-term complication of type 2 diabetes (T2D) widely known to affect the quality of life. Several aspects of altered metabolism in individuals with T2D may help to compromise the penile vasculature structure and functions, thus exacerbating the imbalance between smooth muscle contractility and relaxation. Among these, advanced glycation end-products and reactive oxygen species derived from a hyperglycaemic state are known to accelerate endothelial dysfunction by lowering nitric oxide bioavailability, the essential stimulus of relaxation. Although several studies have explained the pathogenetic mechanisms involved in the generation of erectile failure, few studies to date have described the efficacy of glucose-lowering medications in the restoration of normal sexual activity. Herein, we will present current knowledge about the main starters of the pathophysiology of diabetic ED and explore the role of different anti-diabetes therapies in the potential remission of ED, highlighting specific pathways whose activation or inhibition could be fundamental for sexual care in a diabetes setting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm10112501

Cites

183 of 183 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effects of hyperglycaemia and hypogonadism on endothelial cell and CCSMC dysfunction. AGE, advanced glycation end-product; CCSMCs, corpus cavernosum smooth muscle cells; cGMP, cyclic GMP; eNOS, endothelial nitric oxide synthase; NO, nitric oxide.
Figure 1 Effects of hyperglycaemia and hypogonadism on endothelial cell and CCSMC dysfunction. AGE, advanced glycation end-product; CCSMCs, corpus cavernosum smooth muscle cells; cGMP, cyclic GMP; eNOS, endothelial nitric oxide synthase; NO, nitric oxide.CC BY · PubMed Central
Figure 2 Principal glucose-lowering agents and their downstream pathways that could restore the relaxation of CCSMC and promote erectile function in a diabetic setting. AGE, advanced glycation end-product; AMPD, AMP deaminase; KATP; ATP-sensitive potassium channel; CCSMC, corpus cavernosum smooth muscle cell; cGMP, cyclic GMP; eNOS, endothelial nitric oxide synthase; GLP-1RA, GLP-1 receptor agonist; I4, SU compound; IGF-IR, insulin-like growth factor I receptor; MYPT1, myosin phosphatase target subunit 1; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; PECAM-1, platelet endothelial cell adhesion molecule; ROS, reactive oxygen species, SGLT2i, sodium–glucose cotransporter-2 inhibitor; SUs, sulfonylureas; TZDs, thiazolidinediones. ↓ decrease, ↑ increase.
Figure 2 Principal glucose-lowering agents and their downstream pathways that could restore the relaxation of CCSMC and promote erectile function in a diabetic setting. AGE, advanced glycation end-product; AMPD, AMP deaminase; KATP; ATP-sensitive potassium channel; CCSMC, corpus cavernosum smooth muscle cell; cGMP, cyclic GMP; eNOS, endothelial nitric oxide synthase; GLP-1RA, GLP-1 receptor agonist; I4, SU compound; IGF-IR, insulin-like growth factor I receptor; MYPT1, myosin phosphatase target subunit 1; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; PECAM-1, platelet endothelial cell adhesion molecule; ROS, reactive oxygen species, SGLT2i, sodium–glucose cotransporter-2 inhibitor; SUs, sulfonylureas; TZDs, thiazolidinediones. ↓ decrease, ↑ increase.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. (2021, April 14). Mechanism of Action of Inhibitors of Dipeptidyl-Peptidase-4 (DPP-4) | Elsevier Enhanced Reader. Available online: https://reader.elsevier.com/reader/sd/pii/S1521690X09000232?token=CD1B2CAC3076F481A8BBC18456AF1EF7A483BCC4BD49BB908C4B2A0F620E9D0218ADAEFBC0CDE9B573BAEAE798A9DB99&originRegion=eu-west-1&originCreation=20210414141938.

Cited by

See all 30

Metadata

Authors
Cignarelli, A., Genchi, V. A., D’Oria, R., Giordano, F., Caruso, I., Perrini, S., Natalicchio, A., Laviola, L., & Giorgino, F.
Affiliations
University of Bari Aldo Moro (IT)
Corresponding author
Giorgino, Francesco
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2021-06-05
Volume
10
Issue
11
Pages
2501
ISSN
2077-0383 (ISSN-L)
OpenAlex
W3168626846
Cited by
30
References
184
Citations by year
2026: 4 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 7
FWCI
0.89
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords
erectile dysfunction, type 2 diabetes, glucose-lowering medications, advanced glycation end products, reactive oxygen species, endothelial dysfunction, nitric oxide bioavailability, smooth muscle contractility, sexual function

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.